The MicroGen Vet offering is now closed and is no longer accepting investments.

MicroGen Vet

DNA-Based Microbial Diagnostic Service

Regulation Crowdfunding
Pittsburgh, PA
Biotechnology
Accepting International Investment
Play video

The Most Advanced Microbial Diagnostic Services We Know Of In The Veterinary Marketplace

Invest In: MicroGen Vet

For more than 100 years, veterinarians have been forced to rely on slow and unreliable traditional culturing diagnostics of the past, whereas human diagnostic technology has taken a giant step forward. MicroGen Vet is here to change that. We will bring DNA-based Next Generation Sequencing (NGS) diagnostics to the veterinary marketplace as the exclusive reseller of MicroGen DX diagnostic services


MicroGen DX is the market leader in providing this cutting edge technology to the human diagnostics market - with over 9 years in operation and 300K tests run on human patients. (Source) Now, it's time for veterinarians to benefit from this technology. We bring accurate, quick, and affordable NGS testing services directly from MicroGen DX's laboratories, meaning we're able to immediately fold into the already high volume of human tests, keeping costs low. 


We're the exclusive reseller of this technology that is changing the way vets diagnose their patients. As the understanding of biofilms grows, the need for accurate identification of all microbes in an infection is becoming more and more critical. Veterinary Research Universities have already begun to research the many advantages of this technology. 


In fact, MicroGen Vet is already supporting clinical trials on over 200 horses with both the Rood & Riddle Equine Hospital and Colorado State University's Equine Reproductive Laboratory. Our plan is to make inroads in the U.S. equine and small-animal markets, and then expand to exotic/zoo and livestock markets, and then to grow into international veterinary markets for each.

Invest In MicroGen Vet: Let's Bring Advanced Next Generation Sequencing Into The Veterinary Marketplace

The Offering

Investment
$9.00/Class B Unit│When you invest you are betting MicroGen Vet's future value will exceed $5.7M.


For details on the bonus, please see the Offering Summary below.

Superior Diagnostics. Targeted Treatments. Better Outcomes.

We're Uniquely Positioned To Bring Proven Advanced Technology To The Veterinary Diagnostics Marketplace 

We're the exclusive reseller of Next Generation Sequencing services from the leader in human healthcare: MicroGen DX. This technology is already proven to work with humans: with over 300K tests run to date. And, we believe, growth in the veterinary market will be rapid due to industry purchasing standards and more limited impact of regulations for billing and healthcare in the world of veterinary medicine. 


We're bringing cutting edge technology to the veterinary marketplace, which has been stagnant in the use of traditional culturing for over 100 years. Culturing in this market is ineffective and far out of date given today's DNA-based diagnostic capabilities. 

80%* of infections are biofilm related.


*National Institutes of Health

Only 1%* of known microbes grow under today’s culturing diagnostic tools.


*J.W. Costerton, 

Center For Genomic Sciences

30-35%* of cultures show no growth.


*Dr. Michael Walters, DO

Urologist, Foley AL

Antibiotic resistant bacteria are arising from overuse of broad spectrum antibiotics.*


*Centers for Disease Control

“MicroGen DX’s biofilmatic approach with advanced DNA technology will be the future of how we diagnose and treat chronic infections in the veterinary marketplace.”

Dr. Bimbo Welker

Director of Ohio State Large Animal Services

The Veterinary Market Is Ready

  • There are fewer regulation and billing requirements in the vet market than the human market - this means rapid growth for us.
  • The barrier to entry is high and price competitiveness only comes with high testing volume, which we have with MicroGen DX. 
  • Market education is straightforward through clinical trials and grand round sessions with leading Veterinary Research Universities.
  • Simplified test acquisition is made possible through existing veterinary distribution and channel partners, which also simplifies the operational model for MicroGen Vet.
  • Our Investment dollars will primarily fuel market education efforts and the creation of regional sales and channel teams to drive growth through our business partners.
  • Focused efforts in the U.S. equine and small animal veterinary health markets with expansion to exotic/zoo and livestock markets followed with geographical expansion beyond U.S. markets will lead to sustained growth for the business

MicroGen Vet Is Poised For Success

  • UNIQUE: Next Generation Sequencing (NGS) is the next step beyond Traditional Culture Testing.
  • NECESSARY: We estimate that over 40 million cultures are performed each year in our targeted markets.
  • EXCLUSIVITY: MicroGen DX provides NGS diagnostic services exclusively for MicroGen Vet customers in global veterinary markets.

Our Method Is Efficient 

  • MicroGenDX provides NGS diagnostics as a service. Sample kits are purchased through distribution or online resellers, and samples are simply overnighted to labs for testing.
  • A Level 1 PCR panel report is provided to customer within 24 hrs. It identifies bacteria load, presence of common microbes & antibiotic resistance genes.

  • The Level 2 NGS report is provided to customer within 3-4 days. It identifies every microbe present, along with a list of common antibiotics used for identified microbes.

  • We're able to keep costs low by merging with the high volume of MicroGen DX tests through the same laboratories (DNA is DNA)

Why Next Generation Sequencing?

To understand how NGS is changing the veterinary marketplace, you need only look at how far advanced it is compared to traditional culturing, which dominates diagnostic testing still used across the country by vets today.  NGS technology is far superior, and we believe it will change the industry. 

Traditional Cultures 

  • FRAGILE: Samples must follow strict guidelines of being at the lab within 2 hours - and they must be kept at room temperature
  • UNRELIABLE: Cultures have a high incidence of returning results as "no growth" because less than 1% of known microbes will grow in traditional cultures
  • LENGTHY PROCESS: Can take 20 days for results 

Next Generation Sequencing 

  • STABLE: Samples are not effected by time and temperature
  • ACCURATE: We extract microbial DNA directly from the source (rather than growing it - like traditional cultures). This is similar to finger printing at a crime scene 
  • QUICK RESULTS: Results within 3-5 days with 99.9% accuracy 
  • ANTIBIOTIC RESISTANCE DETECTION: Additionally, we're able to to detect antibiotic resistance genes for 8 antibiotic classes and deliver associated antibiotics information sheet for each patient. 

Our Marketplace

Chronic infections and biofilm education will initially be the focus of the business.  We believe that the Total Attainable Market for sales of NGS services is estimated at:

  • 5-10 Million tests/year 
  • $1 Billion to $2.1 Billion per year

Currently, we are focused initially on equine and small-animal markets but have already received significant interest from national zoos and livestock practitioners. Additionally, we have been contacted by potential partners in Latin America and Canada, which represent significant expansion opportunities in 2019 and beyond.

What We've Done So Far

  • We initially launched at the AAEP Conference in San Antonio in November 2017 and VMX Conference in Orlando in February 2018.
  • Already, MicroGen Vet test kits are distributed through MWI Animal Health and Miller Vet Supply and through online reseller VetCove, with additional channels under review. 
  • Clinical Trials are underway at Rood & Riddle Equine Hospital and at the Colorado State University Equine Reproductive Lab, with several others to come. 

We Participated in the Startup Innovation Circle at the VMX Show In February 2018

There Are Over 35K* Veterinary Practices In Existence 

Those Practices Order 40M* Cultures Every Year 

30* Veterinary Research Universities Provide Thought Leadership to Markets

*Our best estimates of market size and characteristics based on American Veterinary Medical Association (AVMA) and other industry sources.

Invest In MicroGen Vet

Join us in bringing this cutting-edge technology to the world of veterinary health. 


We've already got an amazing and proven product on our hands, which means the next step is to simply distribute it to a marketplace that will benefit from it greatly. Your investment dollars will primarily go toward fueling market education efforts and for building amazing regional sales teams to drive growth through our business partners. 

Offering Summary

Maximum 118,888 Class B Units ($1,069,992)

*Maximum subject to adjustment for bonus units. See 10% Bonus below

Minimum 1,111 Class B Units ($9,999)


Company
MicroGen Vet LLC
 

Corporate Address
1108 Woodland Rd, Pittsburgh PA  15237
 

Description of Business
MicroGen Vet brings what we believe to be the most advanced microbial diagnostic services available from MicroGen DX, the leader in human Next Generation Sequencing, to the world of
veterinary medicine on an exclusive basis to significantly improve animal health outcomes.
 

Type of Security Offered
Class B Units (the "Shares", or the "Securities")
 
Purchase Price of Security Offered
$9.00
 

Minimum Investment Amount (per investor) 
$450












The 10% Bonus for StartEngine Shareholders

MicroGen Vet LLC will offer 10% additional bonus units for all investments that are committed by StartEngine Crowdfunding Inc. shareholders (with ≥ $1,000 invested in the StartEngine Reg A+ campaign) within 24 hours of this offering going live.

StartEngine shareholders who have invested $1,000+ in the StartEngine Reg A+ campaign will receive a 10% bonus on this offering within a 24-hour window of their campaign launch date.  This means you will receive a bonus for any units you purchase.  For example, if you buy 10 Class B Units at $9 / unit, you will receive 1 Class B Bonus Units, meaning you'll own 11 units for $90.   Fractional units will not be distributed and units bonuses will be determined by rounding down to the nearest whole units.

This 10% Bonus is only valid for one year from the time StartEngine Crowdfunding Inc. investors receive their countersigned StartEngine Crowdfunding Inc. subscription agreement.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments and salary made to managing members; Any expense labeled "Travel and Entertainment"

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$22,470.00 USD
$0.00 USD
Cash And Cash Equivalents
$19,875.00 USD
$0.00 USD
Accounts Receivable
$2,595.00 USD
$0.00 USD
Short Term Debt
$0.00 USD
$0.00 USD
Long Term Debt
$0.00 USD
$0.00 USD
Revenues And Sales
$2,595.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$23,085.00 USD
$0.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Final Week to Invest in MicroGen Vet!!!

11 months ago

We certainly hope to see many of those following MicroGen Vet on StartEngine convert to investors this week as Friday is our last day on the platform.  Don't miss your opportunity to participate!


Thanks everyone for your consideration!


MicroGen Vet is on the move! We’ve been busy – check it out…

11 months ago

MicroGen Vet and NGS has been received warmly and with great interest by many top veterinary research universities – multiple visits and talks planned for the Fall

  • Colorado State (June 2018)
  • Cornell
  • Ohio State
  • Texas A&M
  • Virginia Tech
  • UC Davis

Clinical Trials interest growing rapidly with multiple planned for this Fall

  • EQUINE – Lower Respiratory with Tracheal Wash NGS Study – Rood & Riddle
  • EQUINE – Uterine Infections – Comparison of culture, PCR & NGS – CSU
  • EQUINE – Ophthalmology Fungal Infections NGS Study – Texas A&M
  • EQUINE – Orthopedic Joint Infections NGS Study – Cornell and Rood & Riddle
  • SMALL ANIMAL – Dermatology NGS Study – Texas Specialist Clinic
  • SMALL ANIMAL - Ophthalmology Infections NGS Study – Ohio State
  • SMALL ANIMAL – Spinal Fluid NGS Study – Florida Emergency Clinic
  • Others are in discussion

Services have been picked up my multiple leading distribution and resale partners

  • MWI Animal Health
  • Miller Vet Supply
  • VetCove
  • Henry Schein (to be finalized in Sep 2018)
  • Others are planned for 2019

Branding and market reach

  • Over 100,000+ reached and 3,300 website visits driven through Facebook, LinkedIn and Twitter advertising
  • www.microgenvet.com website expanded with clinical papers and videos

Expanding clinical support network

  • Dr. Barr – Equine, Rood & Riddle
  • Dr. Reed - Equine, Rood & Riddle
  • Dr. Rossi – Small Animal, Houston TX
  • Dr. Welker – Equine & Livestock, OSU
  • Dr. Song – Small Animal, Phoenix AZ
  • Dr. Brown – Equine, VT
  • Dr. Metzler – Equine & Small Animal, OSU

Expanding sales support network

  • Northern and Southern California
  • Wyoming, Utah, Idaho, North & South Dakota
  • St. Louis, MO
  • Florida
  • North Carolina
  • Georgia
  • Tennessee
  • Active posting of additional positions around the country

Funding plan still in process

  • StartEngine crowdfunding will come to an end on Sep 28, 2018 for non-accredited investor participation
  • Parallel large accredited investor funding round will commence in Oct 2018

We need your support to provide short term funding in order to continue our push for market education and for recruitment of additional sales support resources to support our distribution partners.  We also plan to participate in several trade shows including AAEP and VMX.  Your investment will support MicroGen Vet as we continue to implement our business model while we secure significant funding for growth through 2019.  Don’t miss this opportunity to participate – it won’t come again!!!  We want folks who are passionate about animal health to join our journey!!! 

Notice of Funds Disbursement

12 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, MicroGen Vet has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in MicroGen Vet be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Notice of Funds Disbursement

about 1 year ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, MicroGen Vet has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in MicroGen Vet be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}